Cumming School of Medicine, University of Calgary, Calgary, Canada.
Department of Medical Genetics, University of Calgary, Calgary, Canada.
Clin Genet. 2021 Mar;99(3):335-346. doi: 10.1111/cge.13882. Epub 2020 Nov 18.
Neurodevelopmental disorders (NDDs) are a heterogeneous group of conditions including intellectual disability, global developmental delay, autism spectrum disorder, and attention deficit hyperactivity disorder. Advances in genetic diagnostic technology have led to the identification of a number of NDD-associated genes, but reports of cognitive and developmental outcomes in affected individuals have been variable. The objective of this scoping review is to synthesize available information pertaining to the developmental outcomes of individuals with pathogenic variants in ten emerging recurrent NDD-associated genes identified from large scale sequencing studies; ADNP, ANKRD11, ARID1B, CHD2, CHD8, CTNNB1, DDX3X, DYRK1A, SCN2A, and SYNGAP1. After a comprehensive search, 260 articles were selected that reported on neurodevelopmental measures or diagnoses. We identify the spectrum of developmental outcomes for each genetic NDD, including prevalence of intellectual disability, frequency of co-morbid NDDs such as ADHD and autism, and commonly reported medical issues that can help inform diagnosis and treatment. There are significant gaps in our understanding of the natural history of these conditions. Future research focusing on barriers to assessment, the development of modified assessment tools appropriate for long-term outcomes in genetic NDD, and collection of longitudinal data will increase understanding of prognosis in these conditions and inform evaluations of treatment.
神经发育障碍 (NDD) 是一组异质性疾病,包括智力障碍、全面发育迟缓、自闭症谱系障碍和注意缺陷多动障碍。遗传诊断技术的进步已经导致了许多与 NDD 相关的基因的鉴定,但受影响个体的认知和发育结果的报告存在差异。本范围综述的目的是综合与从大规模测序研究中确定的十个新兴的常染色体显性遗传 NDD 相关基因(ADNP、ANKRD11、ARID1B、CHD2、CHD8、CTNNB1、DDX3X、DYRK1A、SCN2A 和 SYNGAP1)中存在致病性变异的个体的发育结果相关的可用信息。经过全面搜索,选择了 260 篇报告神经发育测量或诊断的文章。我们确定了每个遗传 NDD 的发育结果范围,包括智力障碍的患病率、ADHD 和自闭症等共患 NDD 的频率,以及常见的报告医疗问题,这些问题有助于提供诊断和治疗信息。我们对这些疾病的自然史的了解还存在很大差距。未来的研究应侧重于评估障碍、为遗传 NDD 的长期结果开发适当的改良评估工具,以及收集纵向数据,以提高对这些疾病预后的理解,并为治疗评估提供信息。